Sun Pharma Wins CDSCO Nod for Generic Oral Semaglutide in India
CDSCO has approved Sun Pharma’s generic once-daily oral semaglutide for type-2 diabetes in India, adding a third oral entrant to a market where Torrent holds about 90% share.
CDSCO has approved Sun Pharma’s generic once-daily oral semaglutide for type-2 diabetes in India, adding a third oral entrant to a market where Torrent holds about 90% share.